Subgen AI Limited (STO:SUBGEN)
0.9670
+0.0240 (2.55%)
At close: Dec 30, 2025
Subgen AI Company Description
Subgen AI Limited develops artificial intelligence-based models and application to control data for government and businesses.
The company also develops and commercializes diagnostic tests for monitoring and optimizing the dosage of biological drugs.
The company is based in London, United Kingdom with additional office in Wilmington, Delaware. Subgen AI Limited operates as a subsidiary of Substrate Artificial Inteligence, S.A.
Subgen AI Limited
| Country | United Kingdom |
| Founded | 2019 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 15 |
| CEO | Lorenzo Serratosa Gallardo |
Contact Details
Address: 1 Bow Churchyard London, EC4M 9DQ United Kingdom | |
| Phone | 46 4 62 86 54 00 |
| Website | subgen.ai |
Stock Details
| Ticker Symbol | SUBGEN |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Lorenzo Serratosa Gallardo | Chief Executive Officer |
| David Jimenez | Chief Financial Officer |